Wang, X., Liang, H., Du, Q., Li, Y., & Zhao, Y. (2025). HACD3 promotes malignant progression of NSCLC by suppressing the MKK7/MAPK10 signaling axis. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14621-y
Chicago Style (17th ed.) CitationWang, Xiaoying, Huijun Liang, Qindan Du, Ying Li, and Yong Zhao. "HACD3 Promotes Malignant Progression of NSCLC by Suppressing the MKK7/MAPK10 Signaling Axis." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14621-y.
MLA (9th ed.) CitationWang, Xiaoying, et al. "HACD3 Promotes Malignant Progression of NSCLC by Suppressing the MKK7/MAPK10 Signaling Axis." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14621-y.
Warning: These citations may not always be 100% accurate.